News & Resources
| [Jul23] GC Wellbeing’s Inibio botulinum toxin gains approval in Peru, targeting Latin America | |||
| Name | KPBMA | ||
|---|---|---|---|
| Registration date | 2025/07/24 | ||
| Links(files, etc.) | |||
|
GC Wellbeing announced on the 22nd that its affiliate Inibio’s botulinum toxin product ‘Inibo’ has obtained a new product license from the Peruvian pharmaceutical regulatory authority. This marks a successful entry into the Latin American market three months after receiving its first overseas approval in Thailand. |
|||
| Prev | [Jul23] GC Biopharma's Inibo botulinum toxin gains approval in Peru, targeting Latin America | ||
| Next | [Jul25] Daewoong expands Middle East presence with Nabota launch in Kuwait | ||